Cohort study reveals higher cervical myelopathy risk with weaker grip and slower pace in adults, suggesting physical markers could aid early detection.
Previous UK Biobank work associated grip strength and usual walking pace with degenerative cervical myelopathy (DCM). We evaluated whether these associations were robust to more specific hospital-record definitions, competing mortality, alternative exposure modeling, and internally validated incremental discrimination. We analyzed 501,936 UK Biobank participants. Grip strength was instrumentally measured, and usual walking pace was self-reported. The primary outcome was any-position hospital-record-defined incident DCM; primary-position DCM and paired hospital diagnosis and cervical procedure records were confirmatory outcomes. Cause-specific Cox models adjusted for age, sex, ethnicity, smoking, body mass index, alcohol intake, diabetes, and hypertension. Grip strength was examined continuously and with restricted cubic splines; walking pace was modeled categorically. Fine-Gray competing-risk models, lagged analyses, interaction tests, and 200-resample bootstrap internal validation were performed. During a median 16.43 years (interquartile range 15.58–17.16; 7,945,865 person-years), 978 participants developed hospital-record-defined DCM (12.31 per 100,000 person-years). The main complete-case analysis included 489,344 participants and 923 events. Each 5-kg higher grip strength was associated with a lower hazard (hazard ratio [HR] 0.859, 95% confidence interval [CI] 0.823–0.896). Relative to brisk pace, steady/average pace (HR 1.274, 95% CI 1.087–1.495) and slow pace (HR 2.543, 95% CI 2.049–3.156) were associated with higher hazards. The grip-strength association was approximately linear (P for nonlinearity = 0.724), and no interaction was evident by sex or age. Primary-position, strict 0–90-day surgery, lagged, and Fine-Gray analyses were directionally consistent. In exploratory internal validation, adding both markers increased the optimism-corrected C-index from 0.650 to 0.680 and the censoring-adjusted 10-year AUC from 0.642 to 0.679; the 10-year Brier-score improvement was numerically very small. Instrumentally measured grip strength and self-reported walking pace were associated with subsequent hospital-record-defined DCM. The results extend previous UK Biobank findings by applying more specific hospital-record definitions, competing-risk methods, evaluation of functional form, and bootstrap internal validation. These nonspecific functional measures may inform future prospective diagnostic research but should not be used as stand-alone screening or triage tests.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: